COVID-19 and liver disease: where are we now?

Patients with end-stage liver disease and COVID-19 are at a higher risk of hospitalization, ventilation and death than those without chronic liver disease. Whether the aetiology of liver disease also affects the natural history of COVID-19 in cirrhosis is debated. Effective and universal vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Francesco Paolo, Burra, Patrizia, Zanetto, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929467/
https://www.ncbi.nlm.nih.gov/pubmed/35301465
http://dx.doi.org/10.1038/s41575-022-00607-9
_version_ 1784670867169476608
author Russo, Francesco Paolo
Burra, Patrizia
Zanetto, Alberto
author_facet Russo, Francesco Paolo
Burra, Patrizia
Zanetto, Alberto
author_sort Russo, Francesco Paolo
collection PubMed
description Patients with end-stage liver disease and COVID-19 are at a higher risk of hospitalization, ventilation and death than those without chronic liver disease. Whether the aetiology of liver disease also affects the natural history of COVID-19 in cirrhosis is debated. Effective and universal vaccination is paramount to combat SARS-CoV-2 infection.
format Online
Article
Text
id pubmed-8929467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89294672022-03-18 COVID-19 and liver disease: where are we now? Russo, Francesco Paolo Burra, Patrizia Zanetto, Alberto Nat Rev Gastroenterol Hepatol Comment Patients with end-stage liver disease and COVID-19 are at a higher risk of hospitalization, ventilation and death than those without chronic liver disease. Whether the aetiology of liver disease also affects the natural history of COVID-19 in cirrhosis is debated. Effective and universal vaccination is paramount to combat SARS-CoV-2 infection. Nature Publishing Group UK 2022-03-17 2022 /pmc/articles/PMC8929467/ /pubmed/35301465 http://dx.doi.org/10.1038/s41575-022-00607-9 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Comment
Russo, Francesco Paolo
Burra, Patrizia
Zanetto, Alberto
COVID-19 and liver disease: where are we now?
title COVID-19 and liver disease: where are we now?
title_full COVID-19 and liver disease: where are we now?
title_fullStr COVID-19 and liver disease: where are we now?
title_full_unstemmed COVID-19 and liver disease: where are we now?
title_short COVID-19 and liver disease: where are we now?
title_sort covid-19 and liver disease: where are we now?
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929467/
https://www.ncbi.nlm.nih.gov/pubmed/35301465
http://dx.doi.org/10.1038/s41575-022-00607-9
work_keys_str_mv AT russofrancescopaolo covid19andliverdiseasewherearewenow
AT burrapatrizia covid19andliverdiseasewherearewenow
AT zanettoalberto covid19andliverdiseasewherearewenow

Ejemplares similares